 | • レポートコード：QY20ST-02045 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥580,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥870,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の組換えヒトフォリトロピン市場について種類別（RHF-α、RHF-β、ウロフォリトロピン）、用途別（フリーズドライパウダー注射、注射）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・組換えヒトフォリトロピン市場の概要 ・世界の主要地域別組換えヒトフォリトロピン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の組換えヒトフォリトロピン市場規模2015-2026：種類別（RHF-α、RHF-β、ウロフォリトロピン） ・世界の組換えヒトフォリトロピン市場規模2015-2026：用途別（フリーズドライパウダー注射、注射） ・組換えヒトフォリトロピンの北米市場規模2015-2020 ・組換えヒトフォリトロピンのヨーロッパ市場規模2015-2020 ・組換えヒトフォリトロピンの中国市場規模2015-2020 ・組換えヒトフォリトロピンの日本市場規模2015-2020 ・組換えヒトフォリトロピンの東南アジア市場規模2015-2020 ・組換えヒトフォリトロピンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・組換えヒトフォリトロピンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・組換えヒトフォリトロピンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Recombinant Human Follitropin Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Recombinant Human Follitropin market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Recombinant human follitropin are drugs that mimic the physiological effects of gonadotropins, used therapeutically mainly as fertility medication for ovarian hyperstimulation and ovulation induction.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Recombinant Human Follitropin market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Recombinant Human Follitropin industry.
Based on our recent survey, we have several different scenarios about the Recombinant Human Follitropin YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant Human Follitropin will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Recombinant Human Follitropin market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Recombinant Human Follitropin market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Recombinant Human Follitropin market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Recombinant Human Follitropin market. The report also includes nautical information, where it shows Recombinant Human Follitropin market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Recombinant Human Follitropin market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Recombinant Human Follitropin market.
For patients undergoing superovulation or assisted reproductive techniques, such as in vitro fertilization-embryo transfer (IVF), gamete intrafallopian transfer (GIFT), and zygote intrafallopian tube transplantation (ZIFT), recombinant human follitropin can stimulate multifollicular development.
Geographical Analysis:
Based on region, the global Recombinant Human Follitropin market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Recombinant Human Follitropin market are
Changchun High & New
Merck Serono
Merck(USA)
Gen Sci
LIVZON
IBSA
Reproductive Health
Ferring
Segment by Type
RHF-α
RHF-β
Urofollitropin
Segment by Application
Freeze-Dried Powder Injection
Injection
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Recombinant Human Follitropin market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Recombinant Human Follitropin market.
• The market share of the global Recombinant Human Follitropin market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Recombinant Human Follitropin market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Recombinant Human Follitropin market.
1 Recombinant Human Follitropin Market Overview
1.1 Recombinant Human Follitropin Product Scope
1.2 Recombinant Human Follitropin Segment by Type
1.2.1 Global Recombinant Human Follitropin Sales by Type (2020-2026)
1.2.2 RHF-α
1.2.3 RHF-β
1.2.4 Urofollitropin
1.3 Recombinant Human Follitropin Segment by Application
1.3.1 Global Recombinant Human Follitropin Sales Comparison by Application (2020-2026)
1.3.2 Freeze-Dried Powder Injection
1.3.3 Injection
1.4 Recombinant Human Follitropin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Recombinant Human Follitropin Sales Growth Rate (2015-2026)
1.4.2 Global Recombinant Human Follitropin Revenue and Growth Rate (2015-2026)
1.4.3 Global Recombinant Human Follitropin Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Recombinant Human Follitropin Industry Impact
1.5.1 How the Covid-19 is Affecting the Recombinant Human Follitropin Industry
1.5.1.1 Recombinant Human Follitropin Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Recombinant Human Follitropin Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Recombinant Human Follitropin Players to Combat Covid-19 Impact
2 Recombinant Human Follitropin Estimate and Forecast by Region
2.1 Global Recombinant Human Follitropin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Recombinant Human Follitropin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Recombinant Human Follitropin Sales Market Share by Region (2015-2020)
2.2.2 Global Recombinant Human Follitropin Revenue Market Share by Region (2015-2020)
2.3 Global Recombinant Human Follitropin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Recombinant Human Follitropin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Recombinant Human Follitropin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Recombinant Human Follitropin Estimates and Projections (2015-2026)
2.4.2 Europe Recombinant Human Follitropin Estimates and Projections (2015-2026)
2.4.3 China Recombinant Human Follitropin Estimates and Projections (2015-2026)
2.4.4 Japan Recombinant Human Follitropin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Recombinant Human Follitropin Estimates and Projections (2015-2026)
2.4.6 India Recombinant Human Follitropin Estimates and Projections (2015-2026)
3 Global Recombinant Human Follitropin Competition Landscape by Players
3.1 Global Top Recombinant Human Follitropin Players by Sales (2015-2020)
3.2 Global Top Recombinant Human Follitropin Players by Revenue (2015-2020)
3.3 Global Recombinant Human Follitropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Follitropin as of 2019)
3.4 Global Recombinant Human Follitropin Average Price by Company (2015-2020)
3.5 Manufacturers Recombinant Human Follitropin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Recombinant Human Follitropin Players (Opinion Leaders)
4 Global Recombinant Human Follitropin Market Size by Type
4.1 Global Recombinant Human Follitropin Historic Market Review by Type (2015-2020)
4.1.1 Global Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
4.1.2 Global Recombinant Human Follitropin Revenue Market Share by Type (2015-2020)
4.1.3 Global Recombinant Human Follitropin Price by Type (2014-2020)
4.2 Global Recombinant Human Follitropin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Recombinant Human Follitropin Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Human Follitropin Revenue Forecast by Type (2021-2026)
4.2.3 Global Recombinant Human Follitropin Price Forecast by Type (2021-2026)
5 Global Recombinant Human Follitropin Market Size by Application
5.1 Global Recombinant Human Follitropin Historic Market Review by Application (2015-2020)
5.1.1 Global Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
5.1.2 Global Recombinant Human Follitropin Revenue Market Share by Application (2015-2020)
5.1.3 Global Recombinant Human Follitropin Price by Application (2015-2020)
5.2 Global Recombinant Human Follitropin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Recombinant Human Follitropin Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Human Follitropin Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Human Follitropin Price Forecast by Application (2021-2026)
3 North America Recombinant Human Follitropin Market Facts & Figures
3.2 North America Recombinant Human Follitropin Sales Market Share by Company (2015-2020)
3.3 North America Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
3.4 North America Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
4 Europe Recombinant Human Follitropin Market Facts & Figures
4.2 Europe Recombinant Human Follitropin Sales Market Share by Company (2015-2020)
4.3 Europe Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
4.4 Europe Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
5 China Recombinant Human Follitropin Market Facts & Figures
5.2 China Recombinant Human Follitropin Sales Market Share by Company (2015-2020)
5.3 China Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
5.4 China Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
6 Japan Recombinant Human Follitropin Market Facts & Figures
6.2 Japan Recombinant Human Follitropin Sales Market Share by Company (2015-2020)
6.3 Japan Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
6.4 Japan Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
7 Southeast Asia Recombinant Human Follitropin Market Facts & Figures
7.2 Southeast Asia Recombinant Human Follitropin Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
8 India Recombinant Human Follitropin Market Facts & Figures
8.2 India Recombinant Human Follitropin Sales Market Share by Company (2015-2020)
8.3 India Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
8.4 India Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Recombinant Human Follitropin Business
12.1 Changchun High & New
12.1.1 Changchun High & New Recombinant Human Follitropin Corporation Information
12.1.2 Changchun High & New Recombinant Human Follitropin Business Overview and Total Revenue
12.1.3 Changchun High & New Recombinant Human Follitropin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Changchun High & New Recombinant Human Follitropin Products Offered
12.1.5 Changchun High & New Recent Development
12.2 Merck Serono
12.2.1 Merck Serono Recombinant Human Follitropin Corporation Information
12.2.2 Merck Serono Recombinant Human Follitropin Business Overview and Total Revenue
12.2.3 Merck Serono Recombinant Human Follitropin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Serono Recombinant Human Follitropin Products Offered
12.2.5 Merck Serono Recent Development
12.3 Merck(USA)
12.3.1 Merck(USA) Recombinant Human Follitropin Corporation Information
12.3.2 Merck(USA) Recombinant Human Follitropin Business Overview and Total Revenue
12.3.3 Merck(USA) Recombinant Human Follitropin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck(USA) Recombinant Human Follitropin Products Offered
12.3.5 Merck(USA) Recent Development
12.4 Gen Sci
12.4.1 Gen Sci Recombinant Human Follitropin Corporation Information
12.4.2 Gen Sci Recombinant Human Follitropin Business Overview and Total Revenue
12.4.3 Gen Sci Recombinant Human Follitropin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Gen Sci Recombinant Human Follitropin Products Offered
12.4.5 Gen Sci Recent Development
12.5 LIVZON
12.5.1 LIVZON Recombinant Human Follitropin Corporation Information
12.5.2 LIVZON Recombinant Human Follitropin Business Overview and Total Revenue
12.5.3 LIVZON Recombinant Human Follitropin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 LIVZON Recombinant Human Follitropin Products Offered
12.5.5 LIVZON Recent Development
12.6 IBSA
12.6.1 IBSA Recombinant Human Follitropin Corporation Information
12.6.2 IBSA Recombinant Human Follitropin Business Overview and Total Revenue
12.6.3 IBSA Recombinant Human Follitropin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 IBSA Recombinant Human Follitropin Products Offered
12.6.5 IBSA Recent Development
12.7 Reproductive Health
12.7.1 Reproductive Health Recombinant Human Follitropin Corporation Information
12.7.2 Reproductive Health Recombinant Human Follitropin Business Overview and Total Revenue
12.7.3 Reproductive Health Recombinant Human Follitropin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Reproductive Health Recombinant Human Follitropin Products Offered
12.7.5 Reproductive Health Recent Development
12.8 Ferring
12.8.1 Ferring Recombinant Human Follitropin Corporation Information
12.8.2 Ferring Recombinant Human Follitropin Business Overview and Total Revenue
12.8.3 Ferring Recombinant Human Follitropin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Ferring Recombinant Human Follitropin Products Offered
12.8.5 Ferring Recent Development
13 Recombinant Human Follitropin Manufacturing Cost Analysis
13.1 Recombinant Human Follitropin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Recombinant Human Follitropin
13.4 Recombinant Human Follitropin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Recombinant Human Follitropin Distributors List
14.3 Recombinant Human Follitropin Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Recombinant Human Follitropin Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Recombinant Human Follitropin Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Recombinant Human Follitropin Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Recombinant Human Follitropin Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Recombinant Human Follitropin Players to Combat Covid-19 Impact
Table 8. Global Market Recombinant Human Follitropin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Recombinant Human Follitropin Sales (Kg) by Region (2015-2020)
Table 10. Global Recombinant Human Follitropin Sales Market Share by Region (2015-2020)
Table 11. Global Recombinant Human Follitropin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Recombinant Human Follitropin Revenue Share by Region (2015-2020)
Table 13. Global Recombinant Human Follitropin Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Recombinant Human Follitropin Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Recombinant Human Follitropin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Recombinant Human Follitropin Revenue Share Forecast by Region (2021-2026)
Table 17. Global Recombinant Human Follitropin (Kg) of Key Companies (2015-2020)
Table 18. Global Recombinant Human Follitropin Sales Share by Company (2015-2020)
Table 19. Global Recombinant Human Follitropin Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Recombinant Human Follitropin Revenue Share by Company (2015-2020)
Table 21. Global Recombinant Human Follitropin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Follitropin as of 2019)
Table 22. Global Recombinant Human Follitropin Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Recombinant Human Follitropin Manufacturing Sites and Area Served
Table 24. Manufacturers Recombinant Human Follitropin Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Recombinant Human Follitropin Players
Table 27. Global Recombinant Human Follitropin Sales (Kg) by Type (2015-2020)
Table 28. Global Recombinant Human Follitropin Sales Share by Type (2015-2020)
Table 29. Global Recombinant Human Follitropin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Recombinant Human Follitropin Price (Kg) by Type (2015-2020)
Table 31. Global Recombinant Human Follitropin Sales Share by Type (2021-2026)
Table 32. Global Recombinant Human Follitropin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Recombinant Human Follitropin Revenue Share by Type (2021-2026)
Table 34. Global Recombinant Human Follitropin Price (Kg) by Type (2021-2026)
Table 35. Global Recombinant Human Follitropin Sales (Kg) by Application (2015-2020)
Table 36. Global Recombinant Human Follitropin Sales Share by Application (2015-2020)
Table 37. Global Recombinant Human Follitropin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Recombinant Human Follitropin Price (Kg) by Application (2015-2020)
Table 39. Global Recombinant Human Follitropin Sales (Kg) by Application (2021-2026)
Table 40. Global Recombinant Human Follitropin Sales Share by Application (2021-2026)
Table 41. Global Recombinant Human Follitropin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Recombinant Human Follitropin Revenue Share by Application (2021-2026)
Table 43. Global Recombinant Human Follitropin Price (Kg) by Application (2021-2026)
Table 44. United States Recombinant Human Follitropin Sales (Kg) by Company (2015-2020)
Table 45. United States Recombinant Human Follitropin Sales Market Share by Company (2015-2020)
Table 46. United States Recombinant Human Follitropin Sales (Kg) by Type (2015-2020)
Table 47. United States Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 48. United States Recombinant Human Follitropin Sales (Kg) by Application (2015-2020)
Table 49. United States Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
Table 50. Europe Recombinant Human Follitropin Sales (Kg) by Company (2015-2020)
Table 51. Europe Recombinant Human Follitropin Sales Market Share by Company (2015-2020)
Table 52. Europe Recombinant Human Follitropin Sales (Kg) by Type (2015-2020)
Table 53. Europe Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 54. Europe Recombinant Human Follitropin Sales (Kg) by Application (2015-2020)
Table 55. Europe Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 56. China Recombinant Human Follitropin Sales (Kg) by Company (2015-2020)
Table 57. China Recombinant Human Follitropin Sales Market Share by Company (2015-2020)
Table 58. China Recombinant Human Follitropin Sales (Kg) by Type (2015-2020)
Table 59. China Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 60. China Recombinant Human Follitropin Sales (Kg) by Application (2015-2020)
Table 61. China Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
Table 62. Japan Recombinant Human Follitropin Sales (Kg) by Company (2015-2020)
Table 63. Japan Recombinant Human Follitropin Sales Market Share by Company (2015-2020)
Table 64. Japan Recombinant Human Follitropin Sales (Kg) by Type (2015-2020)
Table 65. Japan Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 66. Japan Recombinant Human Follitropin Sales (Kg) by Application (2015-2020)
Table 67. Japan Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Recombinant Human Follitropin Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Recombinant Human Follitropin Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Recombinant Human Follitropin Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Recombinant Human Follitropin Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
Table 74. India Recombinant Human Follitropin Sales (Kg) by Company (2015-2020)
Table 75. India Recombinant Human Follitropin Sales Market Share by Company (2015-2020)
Table 76. India Recombinant Human Follitropin Sales (Kg) by Type (2015-2020)
Table 77. India Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 78. India Recombinant Human Follitropin Sales (Kg) by Application (2015-2020)
Table 79. India Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
Table 80. Changchun High & New Corporation Information
Table 81. Changchun High & New Description and Business Overview
Table 82. Changchun High & New Recombinant Human Follitropin Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Changchun High & New Recombinant Human Follitropin Product
Table 84. Changchun High & New Recent Development
Table 85. Merck Serono Corporation Information
Table 86. Merck Serono Description and Business Overview
Table 87. Merck Serono Recombinant Human Follitropin Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Merck Serono Recombinant Human Follitropin Product
Table 89. Merck Serono Recent Development
Table 90. Merck(USA) Corporation Information
Table 91. Merck(USA) Description and Business Overview
Table 92. Merck(USA) Recombinant Human Follitropin Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Merck(USA) Recombinant Human Follitropin Product
Table 94. Merck(USA) Recent Development
Table 95. Gen Sci Corporation Information
Table 96. Gen Sci Description and Business Overview
Table 97. Gen Sci Recombinant Human Follitropin Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Gen Sci Recombinant Human Follitropin Product
Table 99. Gen Sci Recent Development
Table 100. LIVZON Corporation Information
Table 101. LIVZON Description and Business Overview
Table 102. LIVZON Recombinant Human Follitropin Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. LIVZON Recombinant Human Follitropin Product
Table 104. LIVZON Recent Development
Table 105. IBSA Corporation Information
Table 106. IBSA Description and Business Overview
Table 107. IBSA Recombinant Human Follitropin Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. IBSA Recombinant Human Follitropin Product
Table 109. IBSA Recent Development
Table 110. Reproductive Health Corporation Information
Table 111. Reproductive Health Description and Business Overview
Table 112. Reproductive Health Recombinant Human Follitropin Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Reproductive Health Recombinant Human Follitropin Product
Table 114. Reproductive Health Recent Development
Table . Ferring Corporation Information
Table . Ferring Recombinant Human Follitropin Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Ferring Description and Business Overview
Table . Ferring Recombinant Human Follitropin Product
Table . Ferring Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Recombinant Human Follitropin Distributors List
Table 123. Recombinant Human Follitropin Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Follitropin Product Picture
Figure 2. Global Recombinant Human Follitropin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Recombinant Human Follitropin Market Share by Application in 2020 & 2026
Figure 6. Freeze-Dried Powder Injection Examples
Figure 7. Injection Examples
Figure 8. Global Recombinant Human Follitropin Sales (Kg) Growth Rate (2015-2026)
Figure 9. Global Recombinant Human Follitropin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Recombinant Human Follitropin Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 11. Global Recombinant Human Follitropin Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Recombinant Human Follitropin Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Recombinant Human Follitropin Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Recombinant Human Follitropin Sales (Kg) Growth Rate (2015-2026)
Figure 15. Europe Recombinant Human Follitropin Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Recombinant Human Follitropin Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Recombinant Human Follitropin Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Recombinant Human Follitropin Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Recombinant Human Follitropin Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Recombinant Human Follitropin Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Recombinant Human Follitropin Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Recombinant Human Follitropin Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Recombinant Human Follitropin Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Recombinant Human Follitropin Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Recombinant Human Follitropin Players Market Share by Revenue in Recombinant Human Follitropin 2015 & 2019
Figure 26. Recombinant Human Follitropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Recombinant Human Follitropin Revenue Share by Type (2015-2020)
Figure 28. Global Recombinant Human Follitropin Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Recombinant Human Follitropin Revenue Share by Application (2015-2020)
Figure 30. Global Recombinant Human Follitropin Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Recombinant Human Follitropin Sales Market Share by Type in 2019
Figure 32. United States Recombinant Human Follitropin Sales Market Share by Type in 2019
Figure 33. Europe Recombinant Human Follitropin Sales Market Share by Company in 2019
Figure 34. Europe Recombinant Human Follitropin Sales Market Share by Type in 2019
Figure 35. Europe Recombinant Human Follitropin Sales Market Share by Application in 2019
Figure 36. China Recombinant Human Follitropin Sales Market Share by Company in 2019
Figure 37. China Recombinant Human Follitropin Sales Market Share by Type in 2019
Figure 38. China Recombinant Human Follitropin Sales Market Share by Application in 2019
Figure 39. Japan Recombinant Human Follitropin Sales Market Share by Company in 2019
Figure 40. Japan Recombinant Human Follitropin Sales Market Share by Type in 2019
Figure 41. Japan Recombinant Human Follitropin Sales Market Share by Application in 2019
Figure 42. Southeast Asia Recombinant Human Follitropin Sales Market Share by Company in 2019
Figure 43. Southeast Asia Recombinant Human Follitropin Sales Market Share by Type in 2019
Figure 44. Southeast Asia Recombinant Human Follitropin Sales Market Share by Application in 2019
Figure 45. India Recombinant Human Follitropin Sales Market Share by Company in 2019
Figure 46. India Recombinant Human Follitropin Sales Market Share by Type in 2019
Figure 47. India Recombinant Human Follitropin Sales Market Share by Application in 2019
Figure 48. Changchun High & New Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Merck Serono Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Merck(USA) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Gen Sci Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. LIVZON Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. IBSA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Reproductive Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Ferring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Recombinant Human Follitropin
Figure 58. Manufacturing Process Analysis of Recombinant Human Follitropin
Figure 59. Recombinant Human Follitropin Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
遺伝子組換えヒトエリスロポエチン（rhEPO）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Human Erythropoietin (rhEPO) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Reco…- 遺伝子組換えヒト血清アルブミン検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Recombinant Human Serum Albumin Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombin…
- 遺伝子組換えヒト血清アルブミン検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Recombinant Human Serum Albumin Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombin…
- Eptacog Alfa（組換えヒト凝固因子VIIa）の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million i…
- 組換えタンパク質ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Recombinant Protein Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides…